ABOUT 22nd_BEF
> ATTENDEES​
> INVESTORS
> PRESENTERS
> EXHIBITORS
> SPONSORS​​​
> SUPPORTERS​​
+ND Capital
4BIO Capital
AbbVie, Inc.
abcDNA GmbH
Accequa AB
Accure Therapeutics S.L.
ACROBiosystems AG
Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson
Acthera Therapeutics Ltd.
AdBio Partners
Addex Therapeutics Ltd.
Adiposs SA
Adrenomed AG
Advestra AG
Aescuvest International GmbH
AffaMed Therapeutics
Affivant Sciences
Agile Capital Markets
Alithea Bio UG
Alloy Therapeutics, Inc.
Alpha Blue Ocean Ltd.
Alta Life Sciences
Amazon Web Services
AMR Action Fund
Anaveon AG
Andera Partners
Angelini Ventures
Apaxen S.A.
Apex Healthcare Consulting Ltd.
AptaTargets SL
ARTHEx Biotech S.L.
ARTO AG
Asceneuron SA
AstraZeneca
Atamyo Therapeutics SAS
ATGN Consulting
Atlantic Bridge
Atriva Therapeutics GmbH
Avance Basel GmbH
AVANTECA Partners AG
BaseLaunch
BeiGene Ltd.
Belfius Bank
BERNINA BioInvest Ltd.
BioArctic AB
BioFi AG
BioGeneration Ventures
BioInvent International AB
BiomedVC AG
Biomunex Pharmaceuticals
BioNTech SE
BIOSTART Consulting GmbH
Biotech Alliances International, Inc.
BioValley Basel
BioValley Basel & Suterscience, LLC
BioVersys AG
BiPER Therapeutics
Bird & Bird LLP
bmp Ventures AG
Boehler Life Science Advice
Bpifrance
Brandon Capital Partners
Breslin AG & LSFA
Bristol-Myers Squibb
BROTHERS & Partners Europe
Canton of Basel-Stadt
Capital Grand Est
Capricorn Partners
CatalYm GmbH
CBT Advisors
CDR-Life Inc.
CeiROx Life Sciences SA
cellvie AG
Charite
ChinaBio Group
CIS Pharma AG
Convergence Partners AG
Corteria Pharmaceuticals
Coulter Partners
Coura Ventures Ltd
Crescendo Biologics Ltd.
CSL-Vifor
Cukierman & Co. Life Sciences
DAYONE
Debiopharm International S.A
Debiopharm International S.A.
Deep Science Ventures
Delin Ventures Ltd.
Dementia Discovery Fund - SV Health Investors LLP
Digital Networks Plc. S.r.l.
Dillico
Dimericon Therapeutics AG
docdok.health Ltd
docdok.health Ltd.
Domain Therapeutics SA
E.Gutzwiller & Cie, Banquiers
EIT Health e.V.
Elastimed Ltd.
Eli Lilly and Company
Eligo Bioscience
Elikya Therapeutics
Enbiosis Biotechnology
Epsilogen Ltd
Ermium Therapeutics
ESC Advisors
Esperante Ventures
European Investment Fund
Evernow Publishing Ltd.
Eversheds Sutherland (US) LLP
ExcellGene SA
Eyevensys
Fab'entech
Finanz und Wirtschaft
Flerie Invest AB
Forbion
Forty51 Ventures
Fraser Finance LLP
GBC-HpVac SA
Genespire Srl
GeNeuro SA
GenSearch Switzerland GmbH
German Accelerator Life Sciences
Gilde Healthcare Partners
Gimv NV
GL Capital Group
GLSV GmbH
Glycostem Therapeutics B.V.
Grabulovski Consulting Services GmbH
H. Lundbeck A/S
HBM Partners AG
Health Innovation Capital
HealthCap
High-Tech Gründerfonds Management GmbH
Hitachi Ventures GmbH
Hoba Therapeutics ApS
Hoffmann & Partner AG
IAG Italian Angels for Growth
IAMA Therapeutics S.r.l.
IBF - Israel Biotech Fund
ICF Consult Switzerland
IGYXOS SA
Ikxinta Pte Ltd
Immunophotonics, Inc.
Impact Omics BV
InCephalo
Indaco Venture Partners SGR S.p.A.
Independent - FW
Independent - HH
Independent SK
Infinitas Capital
InProTher ApS
Instinctif Partners Ltd.
InterK Peptide Therapeutics Ltd
Intermediate Capital Group PLC
Invasight AG
IOME Bio
iOnctura SA
IPF Partners
JALON THerapeutics
Jefferies International Ltd.
Jeito Capital
JFG Life Sciences Stiftung der Universität Basel
JPMorgan Chase & Co.
Karista
Kekkan Biologics
Kempen & Co
KIZOO Technology Capital GmbH
Kreos Capital
Landmark BioVentures AG
Latham & Watkins LLP
LifeSci Advisors
LifeSci Consulting
LifeSci Partners
LifeSci Search
lifespin GmbH
LiMM Therapeutics SA
Lipigon Pharmaceuticals AB
LMU Munich
Longliv Ventures
Lumanity
LUNAC Therapeutics Ltd
Lynx Financial
Macomics Ltd.
Marker Therapeutics, Inc.
Medicxi
MedTrace Pharma A/S
Memo Therapeutics AG
Mendus AB
MeOhr Ventures
Merck KGaA
MESOX LTD
Metafora Biosystems
Modra Pharmaceuticals BV
Momentum Biotech
Mosanna Therapeutics AG
Nawrath BrightSpots LLC
New Harbor Venture Partners, LLC
NH TherAguix SAS
NLC - Elithia Biotech Fund
Norgine Ventures Management Limited
Novaremed AG
Novartis AG
Novartis Venture Fund
Novo Holdings A/S
Novo Nordisk A/S
NRW.BANK
Numis Securities
NxR Biotechnologies GmbH
OCT Group LLC
ODDO BHF
Omega Fund Management (US), Inc.
OneChain Immunotherapeutics
Onena Medicines
Onena Medicines, S.L.
Optimum Strategic Communications Ltd.
Orion Biotechnology Canada, Ltd.
Oryzon Genomics, S.A.
Osivax
Otsuka Pharmaceuticals Europe Ltd.
Otten Life Sciences Consulting Sàrl
Oxford Finance, LLC
Oxford Science Enterprises
Pan Cancer T B.V.
Panacea Venture
PDC*line Pharma SA
Pfizer, Inc.
PFR Ventures
Pharma Holdings AS
PharmAbcine Inc.
PharmaVentures Ltd.
Photographer
Pictet & Cie.
Pilatus Biosciences SA
Praed Pharmaceuticals Ltd.
Procavea Biotech
Prokarium Ltd.
Pureos Bioventures
Quadrille Capital
Quan Capital
Quotient Sciences
QurAlis
Redalpine Venture Partners AG
Rejuveron Life Sciences AG
Relief Therapeutics Holding SA
Revolo Biotherapeutics
Rewind Therapeutics
Risklick AG
Roca Therapeutics
Roivant Sciences GmbH
Rosetta Capital Ltd.
RYSE Asset Management
Sachs Associates
Salus Partners SA
SCG Chemicals
Schwarz Financial Communication
SciRhom GmbH
Second Thought
Seekyo Therapeutics
Seventure Partners
Silicon Valley Bank
SiSaf Ltd.
SOM Biotech SA
SOTIO Biotech a.s.
Spexis AG
Spirify Pharma, Inc.
SR One
Staatz Business Development & Strategy
STALICLA SA
StemInov
Stifel Europe
STIMUNITY SAS
StromaCare
Stromal Therapeutics AG
Summit Partners Limited
Sunstone Life Science Ventures A/S
Superlab Suisse AG
Swedish Orphan Biovitrum AB
Swiss Biotech Association
Syncona Investment Management Ltd.
Synendos Therapeutics AG
Syneos Health, LLC
TargImmune Therapeutics AG
The FreeMind Group
The Menarini Group
Theralto GmbH
TME Pharma
TOLREMO Therapeutics AG
Torreya
Transimmune AG
TruVenturo GmbH
TVM Capital Life Science
Ultimovacs ASA
Urania Therapeutics
V-Bio Ventures BV
Valor Management S.A.
Ventac Partners A/S
Venture Valuation AG
Venture Valuation Inc.
VI Partners AG
Viopas Venture Consulting
VirdisGroup Sarl
Virometix AG
Vogel BioC
Wellington Partners
WMT AG
XOventure GmbH
Ysios Capital
​
More TBA...
Last updated on: 27th of September